These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33905294)

  • 1. Application of adverse outcome pathway networks to integrate mechanistic data informing the choice of a point of departure for hydrogen sulfide exposure limits.
    Goyak KO; Lewis RJ
    Crit Rev Toxicol; 2021 Mar; 51(3):193-208. PubMed ID: 33905294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium.
    Dorman DC; Moulin FJ; McManus BE; Mahle KC; James RA; Struve MF
    Toxicol Sci; 2002 Jan; 65(1):18-25. PubMed ID: 11752681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory neuron loss in adult male CD rats following subchronic inhalation exposure to hydrogen sulfide.
    Brenneman KA; James RA; Gross EA; Dorman DC
    Toxicol Pathol; 2000; 28(2):326-33. PubMed ID: 10805151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case example of a radiation-relevant adverse outcome pathway to lung cancer.
    Chauhan V; Sherman S; Said Z; Yauk CL; Stainforth R
    Int J Radiat Biol; 2021; 97(1):68-84. PubMed ID: 31846388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen sulfide intoxication.
    Guidotti TL
    Handb Clin Neurol; 2015; 131():111-33. PubMed ID: 26563786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation.
    Chauhan V; Hamada N; Monceau V; Ebrahimian T; Adam N; Wilkins RC; Sebastian S; Patel ZS; Huff JL; Simonetto C; Iwasaki T; Kaiser JC; Salomaa S; Moertl S; Azimzadeh O
    Int J Radiat Biol; 2021; 97(11):1516-1525. PubMed ID: 34402738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An adverse outcome pathway on the disruption of retinoic acid metabolism leading to developmental craniofacial defects.
    Menegola E; Veltman CHJ; Battistoni M; Di Renzo F; Moretto A; Metruccio F; Beronius A; Zilliacus J; Kyriakopoulou K; Spyropoulou A; Machera K; van der Ven LTM; Luijten M
    Toxicology; 2021 Jun; 458():152843. PubMed ID: 34186166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semantic characterization of adverse outcome pathways.
    Wang RL
    Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and carcinogenesis studies of propargyl alcohol (CAS No. 107-19-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Sep; (552):1-172. PubMed ID: 18974778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse outcome pathways and linkages to transcriptomic effects relevant to ionizing radiation injury.
    Yu J; Tu W; Payne A; Rudyk C; Cuadros Sanchez S; Khilji S; Kumarathasan P; Subedi S; Haley B; Wong A; Anghel C; Wang Y; Chauhan V
    Int J Radiat Biol; 2022; 98(12):1789-1801. PubMed ID: 35939063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular Pathway and AOP Development Using Gene Network Analysis].
    Tanabe S; Hirose A; Whelan M; Yamada T
    Yakugaku Zasshi; 2020; 140(4):485-489. PubMed ID: 32238629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory mucosal necrosis in male CD rats following acute inhalation exposure to hydrogen sulfide: reversibility and the possible role of regional metabolism.
    Brenneman KA; Meleason DF; Sar M; Marshall MW; James RA; Gross EA; Martin JT; Dorman DC
    Toxicol Pathol; 2002; 30(2):200-8. PubMed ID: 11950163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
    Ravichandran J; Karthikeyan BS; Samal A
    Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory tract toxicity of inhaled hydrogen sulfide in Fischer-344 rats, Sprague-Dawley rats, and B6C3F1 mice following subchronic (90-day) exposure.
    Dorman DC; Struve MF; Gross EA; Brenneman KA
    Toxicol Appl Pharmacol; 2004 Jul; 198(1):29-39. PubMed ID: 15207646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.
    Sachana M; Rolaki A; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():153-175. PubMed ID: 29524501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events.
    Proctor DM; Suh M; Chappell G; Borghoff SJ; Thompson CM; Wiench K; Finch L; Ellis-Hutchings R
    Regul Toxicol Pharmacol; 2018 Jul; 96():30-40. PubMed ID: 29684431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational fluid dynamics approach to assess interhuman variability in hydrogen sulfide nasal dosimetry.
    Schroeter JD; Garcia GJ; Kimbell JS
    Inhal Toxicol; 2010 Mar; 22(4):277-86. PubMed ID: 20064104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for the adverse outcome pathway framework to support radiation protection?
    Chauhan V; Said Z; Daka J; Sadi B; Bijlani D; Marchetti F; Beaton D; Gaw A; Li C; Burtt J; Leblanc J; Desrosiers M; Stuart M; Brossard M; Vuong NQ; Wilkins R; Qutob S; McNamee J; Wang Y; Yauk C
    Int J Radiat Biol; 2019 Feb; 95(2):225-232. PubMed ID: 30373433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
    Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
    Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse outcome pathways: opportunities, limitations and open questions.
    Leist M; Ghallab A; Graepel R; Marchan R; Hassan R; Bennekou SH; Limonciel A; Vinken M; Schildknecht S; Waldmann T; Danen E; van Ravenzwaay B; Kamp H; Gardner I; Godoy P; Bois FY; Braeuning A; Reif R; Oesch F; Drasdo D; Höhme S; Schwarz M; Hartung T; Braunbeck T; Beltman J; Vrieling H; Sanz F; Forsby A; Gadaleta D; Fisher C; Kelm J; Fluri D; Ecker G; Zdrazil B; Terron A; Jennings P; van der Burg B; Dooley S; Meijer AH; Willighagen E; Martens M; Evelo C; Mombelli E; Taboureau O; Mantovani A; Hardy B; Koch B; Escher S; van Thriel C; Cadenas C; Kroese D; van de Water B; Hengstler JG
    Arch Toxicol; 2017 Nov; 91(11):3477-3505. PubMed ID: 29051992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.